Debilitating chest pain caused by coronary artery disease can significantly impact your quality of life. If you’ve been diagnosed with refractory angina and medicine or other therapies are not helping reduce your persistent pain, Neovasc Reducer* may help you get you back to living your best life.

*Reducer is CE marked. It is not available in every geography.
Important safety information may be found here>



Angina is a type of chest pain, usually a symptom of coronary artery disease (CAD). CAD happens when plaque builds up in the arteries that supply oxygen-rich blood to the heart, forcing the heart to work harder. This is what produces the painful angina, which may feel like pressure or squeezing in the chest, or pain in the shoulders, arms, neck, jaw, or back.

Of all patients experiencing angina, about 10%¹ suffer symptoms that are severe, long lasting, and cannot be controlled by traditional medical, surgical or interventional therapies. This severely debilitating condition is known as refractory angina.


¹Guglielmo Gallone, MD, Luca Baldetti, MD, Georgios Tzanis, MD, Mario Gramegna, MD, Azeem Latib, MD, Antonio Colombo, MD, Timothy D. Henry, MD, Francesco Giannini, MD Refractory Angina From Pathophysiology to New Therapeutic Nonpharmacological Technologies JACC: CARDIOVASCULAR INTERVENTIONS CME/MOC/ECME



Prior to Neovasc’s Reducer there were few, if any, available options for treating chronic refractory angina.

Severe, long lasting and debilitating chest pain that cannot be controlled by traditional medical therapies is known as refractory angina, a condition that can significantly impact quality of life. Reducer* has been shown to provide relief for patients suffering from refractory angina¹.

The Reducer device is a small, hourglass-shaped device that establishes a narrowing in the coronary sinus, altering the blood flow and increasing the supply of oxygenated blood to areas of the heart muscle not receiving enough. Doctors place the device using a minimally invasive procedure, usually performed under local anesthesia. Most patients are discharged within 24 hours. Relief varies by patient and depends on a number of factors, but some patients report relief from angina symptoms as early as six weeks after the procedure, with most patients reporting improvement within three months.

Important safety information to share with your doctor may be found here>

*Reducer is CE marked. It is not available in every geography.
¹EuroIntervention 2021;17:561-568. DOI: 10.4244/EIJ-D-20-00873




Jean, an active 80-year-old Londoner, had started becoming depressed as severe and increasingly untreatable angina negatively affected her quality of life. Her doctor recommended Reducer™* therapy, which helped Jean get her life back.

“If I want to go out, it doesn’t take me half an hour to get out of the house…my life is a lot more social now, and that stops you from being depressed… I’m just glad I had it done and I would advise everybody else that has bad angina, if they’re offered (Reducer Therapy), take it.”

– Jean, Reducer Patient

*Reducer is not available in every geography. For investigational use only in the United States.